X-119872005-G-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004541.4(NDUFA1):āc.94G>Cā(p.Gly32Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00852 in 1,210,338 control chromosomes in the GnomAD database, including 51 homozygotes. There are 3,213 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_004541.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00617 AC: 698AN: 113093Hom.: 6 Cov.: 24 AF XY: 0.00562 AC XY: 198AN XY: 35229
GnomAD3 exomes AF: 0.00566 AC: 1037AN: 183191Hom.: 5 AF XY: 0.00542 AC XY: 367AN XY: 67693
GnomAD4 exome AF: 0.00876 AC: 9612AN: 1097192Hom.: 45 Cov.: 31 AF XY: 0.00832 AC XY: 3015AN XY: 362584
GnomAD4 genome AF: 0.00617 AC: 698AN: 113146Hom.: 6 Cov.: 24 AF XY: 0.00561 AC XY: 198AN XY: 35292
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:5
- -
- -
- -
- -
- -
- -
not specified Benign:4
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
- -
- -
Mitochondrial complex 1 deficiency, nuclear type 12 Benign:3
- -
- -
- -
Mitochondrial complex I deficiency Uncertain:1Other:1
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
- -
NDUFA1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at